FAKTOR-ZERTIFIKAT - TANDEM DIABETES CARE Stock

Certificat

DE000JK5DSK0

Market Closed - Börse Stuttgart 15:42:36 2024-06-28 EDT
0.09 EUR -25.00% Intraday chart for FAKTOR-ZERTIFIKAT - TANDEM DIABETES CARE
Current month-99.25%
1 month-99.16%
Date Price Change
24-06-28 0.09 -25.00%
24-06-27 0.12 +9.09%
24-06-26 0.11 -.--%
24-06-25 0.11 -66.67%
24-06-24 0.33 +3.13%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 03:42 pm

More quotes

Static data

Product typeProduits Exotiques
Buy / SellCALL
Underlying TANDEM DIABETES CARE, INC.
Issuer J.P. Morgan
WKN JK5DSK
ISINDE000JK5DSK0
Date issued 2024-03-22
Strike 36.4 $
Maturity Unlimited
Parity 39.05 : 1
Emission price 10.17
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 12.14
Lowest since issue 0.09
Spread 0.02
Spread %15.38%

Company Profile

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Sector
-
More about the company

Ratings for Tandem Diabetes Care, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Tandem Diabetes Care, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
40.29 USD
Average target price
49.93 USD
Spread / Average Target
+23.93%
Consensus